Impact of N-acetyl-l-cysteine on SARS-CoV-2 pneumonia and its sequelae: results from a large cohort study

Paola Faverio; Paola Rebora; Emanuela Rossi; Savino Del Giudice; Filippo Montanelli; Laura Garzillo; Sara Busnelli; Fabrizio Luppi; Maria Grazia Valsecchi; Alberto Pesci

doi:10.1183/23120541.00542-2021

Impact of N-acetyl-l-cysteine on SARS-CoV-2 pneumonia and its sequelae: results from a large cohort study

ERJ Open Res. 2021 Feb 7;8(1):00542-2021. doi: 10.1183/23120541.00542-2021. eCollection 2022 Jan.

Affiliations

¹ School of Medicine and Surgery, University of Milano Bicocca, Respiratory Unit, San Gerardo Hospital, ASST Monza, Monza, Italy.
² Bicocca Bioinformatics Biostatistics and Bioimaging B4 Center, University of Milano Bicocca, Monza, Italy.

Abstract

Patients receiving N-acetyl-l-cysteine (NAC) during hospitalisation for #SARSCoV2 pneumonia and discharged alive present a significantly shorter length of hospital stay compared to those who did not receive NAC https://bit.ly/3l1QsVo.